4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001415889-25-021423
Options or other derivatives
- Director acquired 22,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pande Vijay Satyanand · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-07 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +22,000 | 22,000 | D |
Loading xslF345X05/form4-08112025_080820.xml…